Pons metabolite alterations in narcolepsy type 1
Neurological Sciences · 2025
DOI: 10.1007/s10072-025-08009-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Micaela Mitolo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, Parma, Italy. Hauptthemen laut MEDLINE: Narcolepsy, Pons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Narcolepsy type 1 (NT1) is a rare central sleep disorder characterized by a selective loss of hypocretin/orexin (hcrt)-producing neurons in the postero-lateral hypothalamus that project to widespread areas of the brain and brainstem. The aim of this study was to explore in a group of NT1 patients the metabolic alterations in the pons and their associations with disease features.
Methods
Twenty-one NT1 patients (16 M) and twenty age-matched healthy controls (10 M) underwent a brain 1 H MRS on a 1.5 T GE Medical Systems scanner. Metabolite content of N-acetyl-aspartate (NAA), choline (Cho), and myo-inositol (mI) were estimated relative to creatine (Cr), using LCModel 6.3. Clinical data were also collected with validated questionnaires, polysomnography, the Multiple Sleep Latency Test (MSLT), Cerebrospinal fluid hypocretin-1 (CSF hcrt-1) concentration and genetic markers.
Results
NT1 patients compared with healthy controls showed lower NAA/Cr ratio ( p = 0.007) and NAA/mI ratio ( p = 0.011) in the pons. The Epworth Sleepiness Scale score showed a significant negative correlation with NAA/Cr content ( p = 0.023), MSLT sleep latency a negative correlation with the mI/Cr ratio ( p = 0.008), and sleep onset REM periods a positive correlation with the mI/Cr ratio ( p = 0.027). CSF hcrt-1 levels were positively correlated with the NAA/Cr ratio ( p = 0.039) and negatively with the mI/Cr ratio ( p = 0.045) and the Cho/Cr ratio ( p = 0.026).
Conclusion
The metabolic alterations found in the pons of NT1 patients using the MR Spectroscopy technique were associated with subjective and objective disease severity measures, highlighting the crucial role of this biomarker in the pathophysiology of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Parma, Parma, Italy.
- Functional and Molecular Neuroimaging Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
- Department for Life Quality Sciences, University of Bologna, Bologna, Italy.
- Department of Life Sciences, Brunel University London, Uxbridge, UK.
Zitieren
APA
Mitolo, M., Pizza, F., Manners, D. N., Guidi, L., Venneri, A., Morandi, L., Tonon, C., Plazzi, G., & Lodi, R. (2025). Pons metabolite alterations in narcolepsy type 1. Neurological Sciences. https://doi.org/10.1007/s10072-025-08009-w
Vancouver
Mitolo M, Pizza F, Manners DN, Guidi L, Venneri A, Morandi L, et al. Pons metabolite alterations in narcolepsy type 1. Neurological Sciences. 2025. doi:10.1007/s10072-025-08009-w
BibTeX
@article{Mitolo2025,
author = {Mitolo, Micaela and Pizza, Fabio and Manners, David Neil and Guidi, Lucia and Venneri, Annalena and Morandi, Luca and Tonon, Caterina and Plazzi, Giuseppe and Lodi, Raffaele},
title = {Pons metabolite alterations in narcolepsy type 1},
journal = {Neurological Sciences},
year = {2025},
doi = {10.1007/s10072-025-08009-w}
}
EUVIMED